Objectives and Specific Aims The goal of cancer treatment is cure without morbidity. Radiation can be an effective locoregional cancer treatment. While any tumor can be killed with enough radiation, any normal tissue can also be injured with sufficient dose to a given volume. The challenge is to deliver the appropriate dose to only those tissues containing tumor. Protons, with no exit dose beyond the target, irradiate less normal tissue than comparable photon (X-ray) fields. This can improve the therapeutic ratio of cure probability to complication risk. While many patients have been treated with protons with impressive clinical results in a number of disease sites, we believe that research can enable and enhance the use of protons in other disease sites. The objective of this multi-institutional program project is to apply advanced proton radiation planning and delivery techniques to improve outcome for patients with non-small cell lung cancer, liver tumors, pediatric medulloblastoma and rhabdomyosarcoma, spine/skull base sarcomas, and paranasal sinus malignancies. We hypothesize that through better use and understanding of the proton range in tissue, and study and management of motion and anatomic changes in the tumor and normal tissues, we can deliver higher precision proton therapy to further improve target coverage and/or reduce dose to nearby critical structures. To test this hypothesis, we propose four integrated projects: (1) Proton Dose Escalation and Proton vs. Photon Randomized Trials for the Treatment of Nonsmall Cell Lung Cancer, (2)lmproving the Therapeutic Ration of Proton Radiation Therapy in Challenging Clinical Sites, (3) Reducing Range Uncertainties in Proton Radiation Therapy, (4) Achieving What-You-See-ls-What-You-Get in Proton Radiation Therapy. The proton physical interactions sufficient to allow smallerspecific aims are to (1) develop an understanding of safety margins as well as more robust and conformal dose distributions, allowing protons to more nearly meet their full potential, and to verify that these advantages can be reliably achieved;(2) use these advantages in randomized clinical trials of protons vs. photons in lung cancer;and (3) to use these advantages in the proton therapy of a number of tumor sites for which protons are judged to have an increasingly important role and which have proven problematic for clinicians in the past.

Public Health Relevance

to Public Health This research aims to improve cancer treatment for patients undergoing radiation therapy by improving our ability to direct the radiation at the tumor and spare adjacent normal tissue by using protons

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-J (M1))
Program Officer
Vikram, Bhadrasain
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Liu, Wei; Liao, Zhongxing; Schild, Steven E et al. (2015) Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers. Pract Radiat Oncol 5:e77-86
Chen, Huixiao; Winey, Brian A; Daartz, Juliane et al. (2015) Efficiency gains for spinal radiosurgery using multicriteria optimization intensity modulated radiation therapy guided volumetric modulated arc therapy planning. Pract Radiat Oncol 5:49-55
Robertson, Daniel; Hui, Cheukkai; Archambault, Louis et al. (2014) Optical artefact characterization and correction in volumetric scintillation dosimetry. Phys Med Biol 59:23-42
Walcott, Brian P; Hattangadi-Gluth, Jona A; Stapleton, Christopher J et al. (2014) Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations. Neurosurgery 74:367-73; discussion 374
Frey, K; Unholtz, D; Bauer, J et al. (2014) Automation and uncertainty analysis of a method for in-vivo range verification in particle therapy. Phys Med Biol 59:5903-19
Ladra, Matthew M; Szymonifka, Jackie D; Mahajan, Anita et al. (2014) Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol 32:3762-70
Sethi, Roshan V; Giantsoudi, Drosoula; Raiford, Michael et al. (2014) Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys 88:655-63
Chen, Huixiao; Craft, David L; Gierga, David P (2014) Multicriteria optimization informed VMAT planning. Med Dosim 39:64-73
Chang, Joe Y; Li, Heng; Zhu, X Ronald et al. (2014) Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys 90:809-18
Cao, Wenhua; Lim, Gino; Liao, Li et al. (2014) Proton energy optimization and reduction for intensity-modulated proton therapy. Phys Med Biol 59:6341-54

Showing the most recent 10 out of 201 publications